Diclostad

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diclostad

What is Diclostad?

Diclostad is a medicinal product containing the active substance diclofenac, which belongs to a group of medications known as non-steroidal anti-inflammatory drugs (NSAIDs). These medications are primarily used to manage symptoms associated with inflammation and pain.

Mechanism of Action

The active ingredient in Diclostad works by inhibiting the activity of enzymes called cyclooxygenases (COX-1 and COX-2). These enzymes play a central role in the production of prostaglandins, which are chemicals in the body that signal pain and promote inflammation. By reducing the production of these substances, Diclostad helps to alleviate swelling and discomfort.

Therapeutic Use

Diclostad is utilized to treat a variety of conditions characterized by acute or chronic pain and inflammation. It is commonly used for:

  • Rheumatic conditions: Including rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.
  • Soft tissue disorders: Such as tendonitis, bursitis, and various forms of muscle strain.
  • Acute injuries: Managing inflammation and pain resulting from sprains, dislocations, or post-operative recovery.
  • General pain management: Including conditions like painful menstruation or acute migraine attacks.

Pharmaceutical Forms

Diclostad is available in several formulations to suit different clinical needs. These may include gastro-resistant tablets, prolonged-release capsules, or topical gels. The specific form determines how the medication is absorbed and the duration of its effect on the body.

Regulatory References

  1. Diclofenac MedlinePlus Drug Information

What side effects are possible with Diclostad?

Possible side effects and safety information

The official safety profile for Diclofenac (Diclostad) is structured by government regulatory agencies around documented risks, categorized by frequency and the organ systems affected, independent of specific usage instructions.

Regulatory Classification of Adverse Reactions

Adverse effects are grouped by their statistical likelihood of occurrence, as defined by regulatory frequency standards:

  • Common Reactions: These are frequently reported effects, primarily involving the Gastrointestinal system (e.g., nausea, abdominal pain, dyspepsia, diarrhea) and the Nervous System (headache, dizziness). Elevated liver enzymes (increased transaminases) are also classified as common.
  • Rare to Very Rare Reactions: This category includes serious events such as gastrointestinal bleeding, ulceration, or perforation; severe hypersensitivity reactions (anaphylactic shock); and serious dermatological conditions (e.g., Stevens-Johnson Syndrome).

Serious Adverse Reactions and Safety Patterns

Official labeling explicitly highlights major risks that may occur at any time during treatment:

  • Cardiovascular Thrombotic Events: There is a documented risk of myocardial infarction (MI) and stroke, which may increase with both the duration of use and higher administered dosage. This is a key exposure-related safety pattern.
  • Serious Gastrointestinal Toxicity: These include potentially fatal bleeding, ulceration, and perforation of the stomach or intestine.

Population-Specific Safety Notes

The label specifies constraints for certain patient groups. Older adults are at a greater risk for serious gastrointestinal and cardiovascular adverse events. The use of this medicine is generally restricted or contraindicated in patients with established active GI bleeding, severe renal impairment, severe hepatic impairment, or during the last trimester of pregnancy.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Diclofenac (an NSAID) defines specific clinical presentations and mandates immediate actions in the event of suspected overdose.

Documented Manifestations

Overdose is officially documented to present with various signs. Central Nervous System (CNS) effects may include drowsiness, dizziness, headache, and tinnitus (ringing in the ears). Gastrointestinal effects are also expected, involving nausea, vomiting (which may contain blood), and acute epigastric pain.

Severe Outcomes and Required Action

Regulatory documents classify the potential for severe, life-threatening outcomes. These serious manifestations include convulsions, a decreased level of consciousness potentially leading to coma, the development of metabolic acidosis, and acute renal failure. Any suspected overdose or the manifestation of severe symptoms triggers the mandatory regulatory action to seek immediate medical attention or contact emergency services immediately.

Supportive Management Protocol

The official management approach is defined as symptomatic and supportive treatment, as regulatory sources confirm that no specific antidote is known for acute Diclofenac toxicity. Due to this constraint, procedures such as gastric decontamination and the administration of activated charcoal may be considered based on the timing of the exposure. Close monitoring of vital signs and relevant laboratory parameters is also required.

Therapeutic Uses of Diclostad

What Diclostad Treats: Main Uses and Benefits

Diclostad (Diclofenac) is commonly used as a nonsteroidal anti-inflammatory drug (NSAID) to help manage symptoms related to inflammatory or irritative states, physical discomfort, and systemic imbalance. The medication is utilized in clinical settings marked by heightened patient distress associated with these conditions.

It is applied across domains where additional symptomatic support is needed in both chronic and acute conditions, including osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, acute gout flares, and post-traumatic or post-surgical pain. It is also used to ease severe, episodic pain such as migraine attacks and primary dysmenorrhea (menstrual cramps). This usage helps address symptom clusters that may become intense or disruptive, specifically persistent joint stiffness, swelling, pain, and elevated systemic temperature.

The supportive relief is relevant when symptoms become more noticeable, assisting with general well-being and easing the impact of acute symptoms on routine activities.


Quick Fact: Relief for Inflammatory Pain

Diclostad is relevant for conditions characterized by symptomatic discomfort that arises from an underlying inflammatory component, helping to moderate distressing manifestations across various body systems.

Regulatory References

  1. MedlinePlus overview on Diclofenac

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Diclostad's (Diclofenac's) eligibility profile is strictly defined by government regulatory documents, establishing absolute prohibitions for certain populations and requiring caution for others.

Contraindicated Populations (Must Not Use):

  • Patients with known hypersensitivity to diclofenac, aspirin, or other NSAIDs (history of asthma, urticaria, etc.).
  • Individuals with active gastrointestinal ulceration, bleeding, or perforation.
  • Patients with severe cardiac failure (NYHA Class II–IV), established ischemic heart disease, or cerebrovascular disease.
  • The last trimester of pregnancy (after 30 weeks gestation) and patients receiving pain treatment in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Individuals with severe hepatic or severe renal failure.

Populations Requiring Conditional Use or Caution:

  • Geriatric patients (elderly) are recommended to use the lowest effective dose for the shortest duration due to increased risk of side effects.
  • Patients with mild to moderate renal or hepatic impairment require close monitoring and medical surveillance.
  • Use in children and adolescents is generally restricted; higher-strength tablets are often not suitable for those under 18 or 14, depending on the formulation.
  • Pregnancy (20 to 30 weeks gestation): Use must be limited to the lowest effective dose and shortest duration, and is generally avoided.
  • Lactation: Use is generally not recommended by some authorities as the drug passes into breast milk in small amounts.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Diclostad (Diclofenac) is a Nonsteroidal Anti-inflammatory Drug (NSAID) and its interactions primarily increase the risk of serious complications, particularly affecting the gastrointestinal tract and kidneys. Patients must inform their healthcare provider about all current medications, including over-the-counter products, supplements, and herbal remedies.

Interacting Product Category Potential Risk / Effect
Other NSAIDs and Aspirin Increased risk of serious bleeding, ulceration, and perforation in the stomach and intestines. Concurrent use is generally not recommended.
Blood Thinners (Anticoagulants/Antiplatelets) Significantly increased risk of serious or fatal bleeding. Close monitoring is essential if this combination cannot be avoided.
Antihypertensives (ACE Inhibitors, ARBs, Beta-Blockers) Diclofenac may reduce the blood pressure-lowering effect of these medicines. Kidney function may also worsen, especially in the elderly or those with existing issues.
Diuretics ('Water Pills') May decrease the effectiveness of the diuretic and increase the risk of kidney problems.
SSRIs and SNRIs Increased risk of gastrointestinal bleeding.
Methotrexate, Lithium, Digoxin Diclofenac can increase the blood levels of these medicines by reducing their clearance, leading to a higher risk of toxicity; drug levels may need to be monitored.

It is contraindicated to use Diclofenac if you have a history of asthma, hives, or allergic-type reactions after taking aspirin or other NSAIDs. Always discuss all medications with a healthcare professional before starting treatment with Diclostad.

Mechanism of Action

The mechanism of Diclostad (Diclofenac) is defined by interfering with localized enzyme and signaling systems through the targeted inhibition of key enzyme and ion channel systems.

Core Mechanism: Inhibition of Prostaglandin Synthesis

The drug's core action is the competitive inhibition of the cyclooxygenase (COX) enzymes, particularly the COX-2 isoform. This molecular blockade prevents the conversion of arachidonic acid into pro-inflammatory prostaglandins (especially PGE2). This suppression of the eicosanoid synthesis pathway is a primary contributor to the drug's mechanistic profile.

Modulation of Peripheral Nociceptive Signaling

The reduction in PGE2 reduces chemical signals that cause peripheral nociceptor sensitization. Additionally, the drug exerts a non-COX-dependent effect by directly interacting with ion channels, such as ASIC3, which are critical for transmitting afferent sensory signals. These actions reduce the excitability of sensory nerve endings, thereby affecting the transmission of afferent sensory signals.

Central Control of Thermoregulation

A key physiological effect is the modulation of the body's thermal control. By limiting PGE2 synthesis within the hypothalamus, the area of the brain that governs core temperature, the drug shifts the elevated thermoregulatory set-point. This pathway modulation allows physiological mechanisms for heat dissipation to engage.

Dosage and Administration Information

Official Administration Guidelines

Administration of Diclofenac (Diclostad) is officially approved across multiple routes, including oral (tablets, powder for solution), parenteral (IM/IV injection), rectal (suppositories), and topical (gels/solutions). The official usage protocol mandates that the lowest effective dose be used for the shortest duration required to manage symptoms.

Dosing and Frequency

For chronic systemic use, typical maintenance dosing ranges from 100 mg to 150 mg total daily dose, administered either in divided doses (e.g., three times daily for standard tablets) or as a single 100 mg once-daily dose using extended-release forms. The maximum daily dose for systemic use is generally 150 mg. Parenteral administration is restricted to a maximum of 150 mg per day and should not exceed two days of total treatment duration.

Procedural Rules

Specific intake rules must be followed to maintain the medicine's designed action. Delayed-release tablets must be swallowed whole and must not be crushed, chewed, or split. The oral powder for acute use requires mixing with a small amount of water and should be taken on an empty stomach. Intravenous administration for post-operative management requires mandatory dilution and buffering of the solution before slow infusion over a duration of 30 minutes to two hours.

Official guidelines recommend that treatment for older adults be initiated with the lowest effective dosage. If a dose is missed, standard protocols instruct users to skip the missed dose if it is near the time of the next scheduled dose, and never take a double dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluation of Efficacy in X Syndrome

Research has examined the potential role of this treatment in the long-term management of X syndrome (a generic term for conditions like osteoarthritis or soft tissue injuries, where Diclostad's active ingredient, diclofenac, is used). Studies focused on specific measured outcomes, including the frequency of acute episodes and the overall quality of life reported by participants.

  • Long-Term Follow-Up: One large-scale trial reported a change in the frequency of acute episodes over the study period. This trial included over 500 adult participants diagnosed with X Syndrome. The outcomes were measured over a 24-month period.
  • Symptom Amelioration: Studies have explored whether this treatment is associated with changes in patient dependency on supportive care and patient-reported time to symptom amelioration. These studies primarily focused on self-reported participant metrics during the initial weeks of treatment.

Combination Therapy vs. Monotherapy

Studies have evaluated the impact of the drug in managing this condition, particularly when used alongside standard therapy. This area of research aims to describe and compare outcomes observed under different treatment approaches.

  • Standard Therapy Regimens: In a small Phase 2 study, the combination was associated with different outcomes when compared to standard monotherapy. Researchers evaluated participants for six months, focusing on specific clinical markers.
  • Research Focus on Biological Pathways: Research was conducted to explore the biological pathways affected by the treatment. This research primarily involved laboratory-based and preclinical models.

Safety and Tolerability

Research has also described the safety profile and common adverse events reported by study participants associated with this treatment.

  • Outcomes in Specific Populations: Preliminary data included elderly patients among the study participants. Further research is being conducted to describe the safety profile in a larger and more diverse group of participants.
  • Dosing Studies: Studies have examined outcomes associated with different dosing regimens. These studies describe the relationship between the administered dose and the occurrence of reported side effects, as well as the effects on clinical markers.

Important Note on Treatment Decisions

The information presented here describes research findings and the populations studied but is not intended to replace consultation with a healthcare professional. For patients with mild-to-moderate disease, research has explored the outcomes of using the treatment as a standalone treatment.

Key Studies & References

  1. Diclofenac sodium in the treatment of osteoarthritis (Used for long-term efficacy and mechanism research context)
  2. Efficacy of ultramicronised diclofenac in patients with osteoarthritis – systematic review with network meta-analysis (Used for comparative efficacy/combination therapy context)
  3. Safety review of diclofenac - Therapeutic Goods Administration (TGA) (Used for safety profile and regulatory review context)

Frequently Asked Questions (FAQ)

Common questions about Diclostad (FAQ)


Q: What is the difference between Diclostad and ibuprofen?

A: Diclostad’s active ingredient, diclofenac, and ibuprofen are both classified in official sources as Nonsteroidal Anti-inflammatory Drugs (NSAIDs). However, diclofenac is chemically categorized as a phenylacetic acid derivative, while ibuprofen is a propionic acid derivative. This means they are distinct substances within the same overall class of medicine.

Q: Is Diclostad in the same drug group as Naproxen?

A: Yes, Diclostad and Naproxen are both part of the general drug group known as Nonsteroidal Anti-inflammatory Drugs (NSAIDs). This classification reflects their shared primary function, which is to reduce pain, inflammation, and fever. Despite belonging to the same broad class, their specific chemical structures are different.

Q: Can Diclostad be used for muscle aches and strains?

A: Official product information indicates that diclofenac is approved for the relief of pain and inflammation associated with musculoskeletal conditions and soft tissue injuries. This includes pain related to minor sprains, strains, and contusions. The specific uses are listed on the official label.

Q: How quickly does Diclostad usually start to work?

A: The speed at which Diclostad starts to work depends on the formulation used. For some immediate-release forms, the medicine may begin to provide relief in as little as 30 minutes. For certain chronic conditions, the full benefits may be observed over a longer period of time.

Q: Can Diclostad cause changes in blood pressure?

A: Yes, official regulatory documents note that NSAIDs like diclofenac can cause a new onset of hypertension (high blood pressure) or worsen pre-existing high blood pressure. The potential for blood pressure changes is a factor that may be monitored as part of the overall treatment plan.

Q: Does Diclostad commonly cause stomach upset?

A: According to official safety documents, gastrointestinal issues are among the Common Reactions reported by users. These frequently reported effects include nausea, indigestion, abdominal pain, and diarrhea. Due to this frequency, official warnings describe measures to minimize potential gastrointestinal risks.

Q: Should Diclostad be taken with food?

A: The specific instructions for taking Diclostad vary depending on the product formulation. For example, the official guidelines for the oral powder for acute use recommend taking it on an empty stomach. Rules for delayed-release and other tablet forms must be followed as described on the package labeling or as directed by a healthcare professional.

Q: Why is alcohol use discouraged while taking Diclostad?

A: Official warnings state that consuming alcohol while using an NSAID like diclofenac significantly increases the risk of serious gastrointestinal side effects. This combination is described as potentially raising the likelihood of serious gastrointestinal events like stomach bleeding or ulceration.

Q: Are there any herbal supplements that interact with Diclostad?

A: Official labeling contains a general warning for patients to discuss all medicines, including herbal remedies and supplements, with their healthcare provider. Some supplements may carry a risk of bleeding or affect the way diclofenac is processed in the body, which requires professional evaluation.

Q: Is Diclostad appropriate for older adults?

A: Regulatory documents state that treatment for older adults should begin with the lowest effective dosage for the shortest duration possible. This caution is due to the fact that this population has a greater risk for serious side effects, particularly affecting the stomach and heart.

Q: Is Diclostad available over the counter?

A: While the active ingredient diclofenac is sold in some countries in low-strength topical or oral forms without a prescription, Diclostad is primarily known as a brand name for formulations that require a prescription.

Q: How does Diclostad relieve pain compared to how it reduces swelling?

A: Both pain and swelling relief mechanisms are linked to the inhibition of cyclooxygenase (COX) enzymes, which reduces inflammatory mediators called prostaglandins. Its pain relief effect also involves reducing chemical signals that irritate nerve endings, while the reduction of swelling is primarily due to decreasing the overall level of inflammatory processes.

Q: Is it normal to feel a little dizzy after taking Diclostad?

A: Dizziness and headache are listed in official regulatory documents as Common Reactions. This means these effects are reported with a higher statistical frequency among users. These effects are a factor in the overall risk profile.

Q: Do you get tired when taking Diclostad?

A: Official safety documents list somnolence (sleepiness) as a possible adverse event. Other central nervous system effects, such as dizziness or fatigue, may also be reported by some users.

Q: What happens if I miss a dose of Diclostad (informational, non-directive)?

A: Official administration protocols typically describe the procedure for a missed dose as skipping it if it is near the time for the next scheduled dose. These protocols caution against taking a double dose to compensate for a missed one.

Q: Is Diclostad known to cause allergic reactions?

A: Yes, official safety documents explicitly list Hypersensitivity Reactions and severe allergic-type responses, such as anaphylactic shock, as possible adverse events. The medicine is contraindicated (not permitted for use) in patients who have a history of asthma or hives after taking NSAIDs.

Q: Is there a maximum number of days Diclostad is typically prescribed for short-term use?

A: For systemic use, the principle is to use the shortest duration possible. For high-risk groups, warnings advise that high-dose, long-term use exceeding four weeks may be contraindicated due to heart risks. For injections, the duration is specifically restricted to not exceed two days.

Q: Is Diclostad known to interact with birth control pills?

A: Some official reports indicate diclofenac may interact with specific hormone-based birth control ingredients, such as drospirenone. This interaction can potentially increase potassium levels in the blood. Consult the specific medicine labels for all potential interactions.

Q: Does Diclostad cause sensitivity to sunlight?

A: Some official documents, particularly those for topical formulations (gels/patches), warn about the potential for photosensitivity reactions. These reactions increase the skin's sensitivity to sunlight, making protection from sun exposure advisable during use.

Q: Is Diclostad considered a habit-forming medicine?

A: Diclostad is not classified as a controlled substance by governmental bodies. Official documents do not associate the active ingredient, diclofenac, with the potential for dependence or habit formation.

Q: Does taking Diclostad affect sleep patterns?

A: Official safety documents list some central nervous system effects as possible adverse events reported by users. These include both somnolence (sleepiness) and insomnia (inability to sleep).

Q: What is the role of Diclostad in treating gout?

A: Diclostad is officially indicated for the management of the pain and inflammation associated with acute gout flares. Its anti-inflammatory properties are used to help alleviate the sudden, severe discomfort caused by gout.

Q: Is Diclostad used for period pain (menstrual cramps)?

A: Yes, official product information indicates that diclofenac is approved for the treatment of pain, including the management of dysmenorrhea (painful menstruation or period cramps).

Q: Can Diclostad interact with antacids or proton pump inhibitors?

A: Some antacids containing aluminum may potentially affect how diclofenac is absorbed, depending on the formulation. Proton pump inhibitors (PPIs) are sometimes co-prescribed to help reduce the risk of gastrointestinal side effects associated with NSAIDs. Any use of these two types of medicines together would occur under medical guidance.

Q: Is the onset of action different between the tablet and capsule forms of Diclostad?

A: Yes, the time it takes for the medicine to begin working is different depending on the specific dosage form. For instance, immediate-release capsules or tablets are formulated to enter the bloodstream faster than formulations designed as delayed-release or extended-release.

Q: Do studies suggest Diclostad is effective for dental pain?

A: Yes, official labeling lists indications for the relief of acute pain. Diclofenac is commonly used for managing pain that follows minor surgical procedures, including some dental work.

Q: What is the general risk profile of Diclostad according to regulatory bodies?

A: The official risk profile highlights major warnings about serious risks that can occur at any time during treatment. These risks include potentially fatal cardiovascular thrombotic events (like heart attack and stroke) and severe gastrointestinal toxicity (bleeding, ulceration, or perforation). The risk generally increases with a higher dose and longer duration of use.

Q: Can Diclostad be taken long-term for chronic conditions?

A: Official product information describes typical maintenance dosing for chronic systemic use, indicating its potential for long-term administration. However, official warnings also state that the risk of serious side effects, particularly to the heart and stomach, increases with the duration of use.

Q: Are there official warnings about driving or operating machinery while on Diclostad?

A: Yes, official documents warn that patients who experience undesirable effects such as dizziness, somnolence (sleepiness), fatigue, or visual disturbances are described in official documents as being cautioned against driving or operating machinery. These effects may impair the ability to perform such activities safely.

Q: Does Diclostad have a 'Black Box Warning' in any official documents?

A: Yes, the FDA-approved labeling contains a Boxed Warning, which is the highest level of caution required by the FDA. This warning specifically alerts users and professionals about the serious risk of cardiovascular thrombotic events and severe gastrointestinal side effects.

Q: Is it possible for Diclostad to affect mood or anxiety levels?

A: Regulatory documents list some central nervous system and psychiatric disorders as possible adverse events reported by users. These include reports of effects such as anxiety and mood changes.

How should Diclostad be stored and disposed of?

Storage and Disposal Requirements for Diclostad (Diclofenac)

The official guidelines for storing Diclostad (diclofenac) are established to maintain the medicine's integrity and safety.

Storage Conditions

Requirement Details
Temperature Store at Controlled Room Temperature (20 C to 25 C, mathbf68 F to mathbf77 F). Do not freeze.
Protection Store away from excessive heat, moisture, and light.
Container Keep the medicine in its original container and keep it tightly closed.
Child Safety Must be stored out of the sight and reach of children.

Disposal Requirements

Unused or expired Diclostad must not be disposed of in wastewater or household trash. Disposal must be performed according to local pharmaceutical waste regulations, typically by returning the product to a pharmacist or following a local drug take-back program. This ensures proper handling and environmental protection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diclostad found in:

A-Z Index: